Advertisement
New Zealand markets closed
  • NZX 50

    11,803.28
    -49.52 (-0.42%)
     
  • NZD/USD

    0.5914
    -0.0007 (-0.11%)
     
  • ALL ORDS

    7,937.90
    +35.90 (+0.45%)
     
  • OIL

    82.70
    +0.80 (+0.98%)
     
  • GOLD

    2,321.10
    -25.30 (-1.08%)
     

Could CRISPR Therapeutics Become the Next Moderna?

Could CRISPR Therapeutics Become the Next Moderna?

CRISPR Therapeutics (NASDAQ: CRSP) has a couple of things in common with a company that's made the headlines over the past few years: coronavirus vaccine maker Moderna (NASDAQ: MRNA). Today, CRISPR's market value sits at about $3.4 billion. Since, Moderna has grown to become a $58 billion company, with a blockbuster product and three more potential ones on the horizon.